Catalent, Inc.
(NYSE : CTLT)

( )
CTLT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. -0.07%30.2414.1%$177.94m
HZNPHorizon Therapeutics Plc 0.00%91.455.5%$174.64m
GWPHGW Pharmaceuticals Plc 0.00%218.366.1%$132.57m
CTLTCatalent, Inc. 0.06%109.982.1%$128.58m
BHCBausch Health Cos., Inc. -0.07%30.240.0%$123.31m
ICLRICON plc 0.00%196.434.2%$121.81m
UTHRUnited Therapeutics Corp. 0.60%204.0014.1%$99.57m
JAZZJazz Pharmaceuticals Plc 0.00%166.372.3%$88.00m
SAVACassava Sciences, Inc. 0.08%35.700.0%$69.85m
ARGXargenx SE 0.81%275.000.0%$51.37m
SAGESAGE Therapeutics, Inc. 0.00%75.677.6%$37.98m
PRGOPerrigo Co. Plc 0.07%40.416.9%$37.14m
AMRNAmarin Corp. Plc 0.98%5.161.5%$29.09m
PCRXPacira Biosciences, Inc. 0.00%69.439.9%$26.96m
ICPTIntercept Pharmaceuticals, Inc. 0.00%21.4116.8%$21.61m

Company Profile

Catalent, Inc. operates as a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale manufacturing of oral solid dose forms for pharmaceutical and consumer health markets, and supporting ancillary services. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing; formulation, development, and manufacturing for parenteral dose forms, which include prefilled syringes, vials, and cartridges; and analytical development and testing services for large molecules. The Oral and Speciality Delivery segment provides advanced formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics in clinical trials. The company was founded in 1933 and is headquartered in Somerset, NJ.